Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1766827016 | Bortezomib (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 1778391012 | Bortezomib | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3523552019 | Product containing bortezomib (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3523553012 | Product containing bortezomib | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3666902014 | Bortezomib product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3713573016 | Bortezomib-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bortezomib-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Bortezomib-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Bortezomib-containing product | Has active ingredient | Bortezomib | true | Inferred relationship | Some | 1 | |
| Bortezomib-containing product | Is a | Proteasome inhibitor-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bortezomib only product | Is a | True | Bortezomib-containing product | Inferred relationship | Some | |
| Bortezomib-containing product in parenteral dose form | Is a | True | Bortezomib-containing product | Inferred relationship | Some | |
| Bortezomib 3.5mg lyophilized powder for injection | Is a | False | Bortezomib-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR